Description
Cagrilintide and semaglutide in equal amounts in one vial (2.5mg + 2.5mg or 5mg + 5mg), the amylin and GLP-1 combination known as “CagriSema”. Research uses it to study combined amylin and GLP-1 receptor activity in appetite and body-weight regulation.
Supplied by LiliPeptide in boxes of 10 vials, priced per box. The strength shown is the amount in each vial.
For research use only. Not for human or veterinary use.





